CC
Chemours Co
NYSE · Basic Materials · Chemicals - Specialty · US
$13.82
+5.50%Year over year
Reported trailing growth
- Revenue
- -0.5%
- EBITDA
- -98.5%
- EBIT
- —
- EPS
- +50.0%
- Free cash flow
- +1083.3%
- Operating cash flow
- +34.3%
Forward estimates
Based on analyst estimates
- Revenue
- +6.1%
- EBITDA
- —
- EPS
- +255.0%
Three-year CAGR
- Revenue
- -5.3%
- EBITDA
- -34.7%
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- -51.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2026